134 related articles for article (PubMed ID: 16412401)
1. OxLDL enhances L-type Ca2+ currents via lysophosphatidylcholine-induced mitochondrial reactive oxygen species (ROS) production.
Fearon IM
Cardiovasc Res; 2006 Mar; 69(4):855-64. PubMed ID: 16412401
[TBL] [Abstract][Full Text] [Related]
2. Peroxynitrite formation mediates LPC-induced augmentation of cardiac late sodium currents.
Gautier M; Zhang H; Fearon IM
J Mol Cell Cardiol; 2008 Feb; 44(2):241-51. PubMed ID: 17961592
[TBL] [Abstract][Full Text] [Related]
3. Modulation of nonselective cation current by oxidized LDL and lysophosphatidylcholine and its inhibitory contribution to endothelial damage.
Liang GH; Park S; Kim MY; Kim JA; Choi S; Suh SH
Life Sci; 2010 May; 86(19-20):733-9. PubMed ID: 20226792
[TBL] [Abstract][Full Text] [Related]
4. Bidirectional regulation of Ca2+ sparks by mitochondria-derived reactive oxygen species in cardiac myocytes.
Yan Y; Liu J; Wei C; Li K; Xie W; Wang Y; Cheng H
Cardiovasc Res; 2008 Jan; 77(2):432-41. PubMed ID: 18006452
[TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidylcholine enhances I(Ks) currents in cardiac myocytes through activation of G protein, PKC and Rho signaling pathways.
Ding WG; Toyoda F; Ueyama H; Matsuura H
J Mol Cell Cardiol; 2011 Jan; 50(1):58-65. PubMed ID: 20950624
[TBL] [Abstract][Full Text] [Related]
6. H2O2 regulates recombinant Ca2+ channel alpha1C subunits but does not mediate their sensitivity to acute hypoxia.
Hudasek K; Brown ST; Fearon IM
Biochem Biophys Res Commun; 2004 May; 318(1):135-41. PubMed ID: 15110764
[TBL] [Abstract][Full Text] [Related]
7. Different mechanisms of lysophosphatidylcholine-induced Ca(2+) mobilization in N2a mouse and SH-SY5Y human neuroblastoma cells.
Li XH; Long DX; Li W; Wu YJ
Neurosci Lett; 2007 Aug; 424(1):22-6. PubMed ID: 17703881
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidylcholine-induced modulation of Ca(2+)-activated K(+)channels contributes to ROS-dependent proliferation of cultured human endothelial cells.
Wolfram Kuhlmann CR; Wiebke Lüdders D; Schaefer CA; Kerstin Most A; Backenköhler U; Neumann T; Tillmanns H; Erdogan A
J Mol Cell Cardiol; 2004 May; 36(5):675-82. PubMed ID: 15135662
[TBL] [Abstract][Full Text] [Related]
9. Pro-oxidant mitochondrial matrix-targeted ubiquinone MitoQ10 acts as anti-oxidant at retarded electron transport or proton pumping within Complex I.
Plecitá-Hlavatá L; Jezek J; Jezek P
Int J Biochem Cell Biol; 2009; 41(8-9):1697-707. PubMed ID: 19433311
[TBL] [Abstract][Full Text] [Related]
10. Evidence for regulation of mitochondrial function by the L-type Ca2+ channel in ventricular myocytes.
Viola HM; Arthur PG; Hool LC
J Mol Cell Cardiol; 2009 Jun; 46(6):1016-26. PubMed ID: 19166857
[TBL] [Abstract][Full Text] [Related]
11. Transient-outward K+ channel inhibition facilitates L-type Ca2+ current in heart.
Wang Y; Cheng J; Tandan S; Jiang M; McCloskey DT; Hill JA
J Cardiovasc Electrophysiol; 2006 Mar; 17(3):298-304. PubMed ID: 16643405
[TBL] [Abstract][Full Text] [Related]
12. Multiple actions of lysophosphatidylcholine in human Jurkat T cells.
Im YJ; Lee YK; Chung HY; Im DS
Acta Pharmacol Sin; 2006 Jun; 27(6):700-7. PubMed ID: 16723088
[TBL] [Abstract][Full Text] [Related]
13. Transient exposure to hydrogen peroxide causes an increase in mitochondria-derived superoxide as a result of sustained alteration in L-type Ca2+ channel function in the absence of apoptosis in ventricular myocytes.
Viola HM; Arthur PG; Hool LC
Circ Res; 2007 Apr; 100(7):1036-44. PubMed ID: 17347474
[TBL] [Abstract][Full Text] [Related]
14. Intracellular Ca(2+)- and PKC-dependent upregulation of T-type Ca(2+) channels in LPC-stimulated cardiomyocytes.
Zheng M; Wang Y; Kang L; Shimaoka T; Marni F; Ono K
J Mol Cell Cardiol; 2010 Jan; 48(1):131-9. PubMed ID: 19744490
[TBL] [Abstract][Full Text] [Related]
15. Dystrophic cardiomyopathy: amplification of cellular damage by Ca2+ signalling and reactive oxygen species-generating pathways.
Jung C; Martins AS; Niggli E; Shirokova N
Cardiovasc Res; 2008 Mar; 77(4):766-73. PubMed ID: 18056762
[TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidylcholine augments Ca(v)3.2 but not Ca(v)3.1 T-type Ca(2+) channel current expressed in HEK-293 cells.
Zheng M; Uchino T; Kaku T; Kang L; Wang Y; Takebayashi S; Ono K
Pharmacology; 2006; 76(4):192-200. PubMed ID: 16543777
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the extracellular divalent cation-inhibited non-selective conductance in cardiac cells by metabolic inhibition and by oxidants.
Macianskiene R; Matejovic P; Sipido K; Flameng W; Mubagwa K
J Mol Cell Cardiol; 2001 Jul; 33(7):1371-85. PubMed ID: 11437543
[TBL] [Abstract][Full Text] [Related]
18. The Na+/Ca2+ exchange blocker SEA0400 fails to enhance cytosolic Ca2+ transient and contractility in canine ventricular cardiomyocytes.
Birinyi P; Tóth A; Jóna I; Acsai K; Almássy J; Nagy N; Prorok J; Gherasim I; Papp Z; Hertelendi Z; Szentandrássy N; Bányász T; Fülöp F; Papp JG; Varró A; Nánási PP; Magyar J
Cardiovasc Res; 2008 Jun; 78(3):476-84. PubMed ID: 18252759
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of L-type Ca2+ channel by mitochondrial Na+-Ca2+ exchange inhibitor CGP-37157 in rat atrial myocytes.
Thu le T; Ahn JR; Woo SH
Eur J Pharmacol; 2006 Dec; 552(1-3):15-9. PubMed ID: 17054940
[TBL] [Abstract][Full Text] [Related]
20. T-type Ca2+ channel blockers prevent cardiac cell hypertrophy through an inhibition of calcineurin-NFAT3 activation as well as L-type Ca2+ channel blockers.
Horiba M; Muto T; Ueda N; Opthof T; Miwa K; Hojo M; Lee JK; Kamiya K; Kodama I; Yasui K
Life Sci; 2008 Mar; 82(11-12):554-60. PubMed ID: 18275974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
